Oslo, Norway (29 March 2021 ) - Reference is made to the offer document dated8 March 2021 (the "Offer Document") for the recommended voluntary offer by Compagnie des Levures Lesaffre (the "Offeror") to acquire all outstanding shares inNattoPharma ASA ("NattoPharma " or the "Company") against a consideration in cash ofNOK 35 per share (the "Offer"), and further reference is made to the stock exchange announcement dated29 March 2021 in which the Offeror announced that the voluntary offer is completed. The Offeror had obtained pre-commitments from Shareholders representing approximately 65.10% (on a Fully Diluted basis, excluding treasury shares) of the Shares to tender their Shares pursuant to the Offer. The pre-commitments included 1,655,122 shares by primary insiders of the Company and 7,855,611 shares by close associates of primary insiders of the Company (as listed below): · Bohan & Co AS as close associate to Chairman of the Board sold 1,298,455 shares in this transaction. Following this transaction Bohan & Co AS will not hold any shares inNattoPharma . · TG Montgomery AS as close associate to Chairman of the BoardFrode Bohan and deputy Board Member Kim Øien sold 2,121,482 shares in this transaction. Following this transaction TG Montgomery AS will not hold any shares inNattoPharma . · Patrycja Ratunsinska as close associatie to Chairman of the Board sold 350,000 shares in this transaction. Following this transaction Patrycja Ratunsinska will not hold any shares inNattoPharma . · Primary insider and Chairman of the BoardFrode Bohan sold 100,000 shares in this transaction. Following this transactionFrode Bohan will not hold any shares inNattoPharma . · Nicole Invest AS as close associate to deputy Board Member Kim Øien sold 200,000 shares in this transaction. Following this transaction Nicoline Invest AS will not hold any shares inNattoPharma . · Grethe Eggesbøe Thorsheim as close associate to Board MemberSjur Thorsheim sold 21,000 in this transaction. Following this transaction Grethe Eggesbøe Thorsheim will not hold any shares inNattoPharma . · Pro AS as close associate to Board MemberSjur Thorsheim sold 2,861,310 shares in this transaction. Following this transaction Pro AS will not hold any shares inNattoPharma . · Primary insider and Board MemberSjur Thorsheim sold 100,000 shares in this transaction. Following this transactionSjur Thorsheim will not hold any shares inNattoPharma . ·Life Science Sweden AB as close associate to Board MemberStefan Hallden sold 647,654 shares in this transaction. Following this transactionLife Science Sweden AB will not hold any shares inNattoPharma . · Primary insider and Board MemberStefan Hallden sold 310,800 shares in this transaction. Following this transactionStefan Hallden will not hold any shares inNattoPharma . ·Tontine AB as close associate to Board MemberStefan Hallden sold 81,210 shares in this transaction. Following this transactionTontine AB will not hold any shares inNattoPharma . · Primary insider and Board MemberAnnette Elmqvist sold 150,000 shares in this transaction. Following this transaction Annette Elmqvist will not hold any shares inNattoPharma . · Primary insider and Board MemberKatarzyna Maresz sold 125,000 shares in this transaction. Following this transactionKatarzyna Maresz will not hold any shares inNattoPharma . · Cinco Invest AS as close associate to Chief Executive OfficerKjetil Ramsøy sold 300,000 shares in this transaction. Following this transaction Cinco Invest AS will not hold any shares inNattoPharma . · Primary insider and Chief Executive OfficerKjetil Ramsøy sold 275,100 shares in this transaction. Following this transaction Kjetil Ramsøy will not hold any shares inNattoPharma . · Primary insider and Chief Financial OfficerRobert Schrama sold 33,000 shares in this transaction. Following this transactionRobert Schrama will not hold any shares inNattoPharma . · Primary insiderElise Kaiser sold 40,000 shares in this transaction. Following this transactionElise Kaiser will not hold any shares inNattoPharma . · Primary insiderLaura Bakker sold 81,000 shares in this transaction. Following this transactionLaura Bakker will not hold any shares inNattoPharma . · Primary insiderAndrew Green sold 20,000 shares in this transaction. Following this transactionAndrew Green will not hold any shares inNattoPharma . · Primary insiderRandall Eric Anderson sold 191,750 shares in this transaction. Following this transactionRandall Eric Anderson will not hold any shares inNattoPharma . · Primary insiderRudi De Man sold 86,000 shares in this transaction. Following this transactionRudi De Man will not hold any shares inNattoPharma . ·RDM Health & Nutrition BVBA as close associate to Primary InsiderRudi De Man sold 60,500 shares. Following this transactionRDM Health & Nutrition BVBA will not hold any shares inNattoPharma . · Primary insiderWilliam Sommer sold 142,472 shares in this transaction. Following this transactionWilliam Sommer will not hold any shares inNattoPharma . Please refer to the attached notifications of trading for further details. *** For more information, please contact:Robert Schrama , CFO E-mail: robert.schrama@nattopharma.com This information is subject to the disclosure requirements pursuant to section 5 -12 of theNorwegian Securities
Click here for more information
© Oslo Bors ASA, source